Table 1.
baseline data to compare two groups of patients before treatment.
| Item | CAS group (n = 50) | CEA group (n = 48) | t/x2 | P |
|---|---|---|---|---|
| Age (years) | 52.48 ± 4.78 | 53.14 ± 4.82 | 0.68 | 0.49 |
| M/F (n) | 26/24 | 23/25 | 0.16 | 0.68 |
| Diabetes (n) | 15 | 12 | 0.02 | 0.87 |
| Hypertension (n) | 22 | 19 | 0.31 | 0.57 |
| Stroke (n) | 8 | 7 | 0.65 | 0.25 |
| Smoke (n) | 28 | 30 | 0.81 | 0.36 |
| Drinke (n) | 26 | 24 | 0.98 | 0.45 |
| Education (level) | 3.21 ± 0.51 | 3.34 ± 0.54 | 1.22 | 0.22 |
| BMI (kg/m2) | 1.24 ± 1.12 | 16.89 ± 1.04 | 1.60 | 0.11 |
| Total cholesterol (mmol/l) | 4.82 ± 0.64 | 5.01 ± 0.67 | 1.43 | 0.15 |
| LDL-C (mmol/l) | 2.89 ± 0.44 | 3.05 ± 0.49 | 1.70 | 0.09 |
| HDL-C (mmol/L) | 1.07 ± 0.20 | 1.02 ± 0.24 | 1.11 | 0.27 |
| Hcy (μmol/l) | 15.75 ± 3.23 | 16.15 ± 3.35 | 0.60 | 0.54 |
| Glycated hemoglobin | 6.08 ± 0.62 | 6.10 ± 0.78 | 0.14 | 0.89 |
| Folic acid (mmol/L) | 8.91 ± 1.98 | 9.33 ± 2.34 | 0.95 | 0.34 |
| Vitamin B12 (pmol/L) | 325.05 ± 98.76 | 331.77 ± 102.06 | 0.32 | 0.74 |
M/F: male/female; BMI: body mass index; HDL-C: high-density lipoprotein-cholesterol; LDL-C: low high-density lipoprotein-cholesterol.